These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2338866)

  • 21. [Prenatal evaluation of fetal health by integrated biophysical methods].
    Spagnuolo L; Fiore M; Patronelli CG
    Minerva Ginecol; 1988 Oct; 40(10):571-6. PubMed ID: 3221998
    [No Abstract]   [Full Text] [Related]  

  • 22. Maternal Addison's disease and fetal growth retardation. A case report.
    O'Shaughnessy RW; Hackett KJ
    J Reprod Med; 1984 Oct; 29(10):752-6. PubMed ID: 6512785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early fetal growth retardation: obstetric background and recurrence rate.
    Visser GH; Huisman A; Saathof PW; Sinnige HA
    Obstet Gynecol; 1986 Jan; 67(1):40-3. PubMed ID: 3940335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antenatal diagnosis of intrauterine hypotrophy--methods and results].
    Radzuwait G; Dal I
    Akush Ginekol (Sofiia); 1986; 25(3):8-13. PubMed ID: 3752403
    [No Abstract]   [Full Text] [Related]  

  • 25. [Screening examination for detection of intrauterine fetal dystrophy].
    Uszyński M; Koźmińska T
    Pol Tyg Lek; 1982 Sep; 37(32):941-2. PubMed ID: 7167407
    [No Abstract]   [Full Text] [Related]  

  • 26. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy.
    Steinborn A; Varkonyi T; Scharf A; Bahlmann F; Klee A; Sohn C
    Am J Reprod Immunol; 2007 Apr; 57(4):277-86. PubMed ID: 17362389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primordial growth deficiency--a case report for the diagnosis of early intrauterine growth retardation].
    Klug PW; Krainer F
    Z Geburtshilfe Perinatol; 1986; 190(3):137-9. PubMed ID: 3532596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound evaluation of intrauterine growth retardation.
    Little D; Campbell S
    Radiol Clin North Am; 1982 Jun; 20(2):335-51. PubMed ID: 7100429
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prenatal diagnosis and maternal and child health].
    Camarena Bolaños JM
    An Esp Pediatr; 1990 Oct; 33 Suppl 41():63-6. PubMed ID: 2278465
    [No Abstract]   [Full Text] [Related]  

  • 30. Cocaine use in women from a defined population: prevalence at delivery and effects on growth in infants.
    Weathers WT; Crane MM; Sauvain KJ; Blackhurst DW
    Pediatrics; 1993 Feb; 91(2):350-4. PubMed ID: 8424009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired fetal growth: definition and clinical diagnosis.
    Seeds JW
    Obstet Gynecol; 1984 Sep; 64(3):303-10. PubMed ID: 6379528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fetal growth from the AUDIPOG study. II. Application for the diagnosis of intrauterine growth retardation].
    Mamelle N; Munoz F; Martin JL; Laumon B; Grandjean H
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(1):71-7. PubMed ID: 8901305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Risk factors for low birth weight and intrauterine growth retardation in Santiago, Chile].
    Vega J; Sáez G; Smith M; Agurto M; Morris NM
    Rev Med Chil; 1993 Oct; 121(10):1210-9. PubMed ID: 8191127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The present status of ultrasound in obstetrics.
    Neilson JP; Hood VD; Whitfield CR
    Br J Hosp Med; 1982 Mar; 27(3):236, 238-41. PubMed ID: 7074258
    [No Abstract]   [Full Text] [Related]  

  • 35. [Better individual adaptation in future maternal health care. Routine check-ups are based on weak scientific grounds].
    Lindmark G; Cnattingius S
    Lakartidningen; 1991 Jan; 88(5):331-4. PubMed ID: 1997773
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ultrasonic monitoring of intrauterine fetal growth retardation].
    Gao SH
    Zhonghua Fu Chan Ke Za Zhi; 1988 May; 23(3):142-4, 188. PubMed ID: 3058416
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnosis and therapy of fetal thyroid gland dysfunction in primary maternal disease].
    Haeusler MC; Pertl B
    Acta Med Austriaca; 1997; 24(4):159-61. PubMed ID: 9441555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perinatal circulating visfatin levels in intrauterine growth restriction.
    Malamitsi-Puchner A; Briana DD; Boutsikou M; Kouskouni E; Hassiakos D; Gourgiotis D
    Pediatrics; 2007 Jun; 119(6):e1314-8. PubMed ID: 17502346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intrauterine growth retardation. Changes in obstetrical practice in France].
    Poisson-Salomon AS; Bréart G
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(2):163-71. PubMed ID: 3294998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiphospholipid antibodies and growth retardation in intrauterine development.
    Spegiorin LC; Galão EA; De Godoy JM; Bagarelli LB; Oliani AH
    Prague Med Rep; 2007; 108(2):185-90. PubMed ID: 18225645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.